Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Mycronic AB ( (SE:MYCR) ) is now available.
Mycronic AB reported a 35% increase in net sales for the second quarter of 2025, driven by strong growth in Pattern Generators, High Volume, and Global Technologies, despite a 37% decline in order intake. The company completed acquisitions of RoBAT and Surfx Technologies, enhancing its capabilities in PCB testing and surface treatment solutions. The outlook for 2025 has been revised upward, reflecting confidence in achieving higher net sales, supported by a strong performance in the Chinese market and strategic expansions.
More about Mycronic AB
Mycronic AB operates in the electronics manufacturing industry, specializing in advanced production equipment and solutions for PCB assemblies, photomask markets for displays and semiconductors, and surface treatment technologies. The company is focused on expanding its market presence through strategic acquisitions and enhancing its product offerings across various business lines, including PCB Test, Die Bonding, and Applied Plasma.
Average Trading Volume: 226,733
Current Market Cap: SEK39.71B
Learn more about MYCR stock on TipRanks’ Stock Analysis page.